3 Healthcare & Biotech Stocks up over 53% past 10 days
Powered by HealthTechMovers.com
Below is a list of 2 Healthcare & Biotech Stocks up over 53% past 10 days and have been added to our watchlist. Keep in mind, these are very volatile stocks so please do your own research before you make any investments. While we do list the ratings of various 3rd party services, we are not recommending these stocks and we are not paid by these companies, we simply report the big movers. If the editor has a position in any of these securities, it will be noted below the chart.
iSpecimen, ISPC
Summary: iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass.
Ticker | Company | Sector | Previous Close | *Last Price | % Price Change Past 10 Days |
ISPC | iSpecimen | Healthcare & Biotech | n/a | $14.1 | n/a |
Here are 3rd party ratings for ISPC:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: N/A
Ticker | Company | Sector | Previous Close | *Last Price | % Price Change Past 10 Days |
BLFE | Biolife Sciences | Healthcare & Biotech | n/a | $1.98 | n/a |
Here are 3rd party ratings for BLFE:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Ticker | Company | Sector | Previous Close | *Last Price | % Price Change Past 10 Days |
CPIX | Cumberland Pharmaceuticals | Healthcare & Biotech | n/a | $4.34 | n/a |
Here are 3rd party ratings for CPIX:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------